Home > Insider Trading > Filing (0001140361-17-016840)

Filing Details

Accession Number:: 0001140361-17-016840
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-04-26 14:39:52
Reporting Period:: 2017-04-24

Filing Date:: 2017-04-26
Accepted Time:: 2017-04-26 14:39:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1001902	Intevac Inc	IVAC	Special Industry Machinery, Nec (3559)	943125814

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1325447	First Eagle Investment Management, Llc	1345 Avenue Of The Americas 44Th Floor New York NY 10105	No	No	Yes	No
1457518	First Eagle Value In Biotechnology Master Fund, Ltd.	Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205	No	No	Yes	No
1459708	21 April Fund, Ltd.	Citco Fund Services (Cayman Islands) Ltd Regatta Office Park West Bay Road Grand Cayman E9 KY1-1205	No	No	Yes	No
1637141	First Eagle Holdings, Inc.	1345 Avenue Of The Americas New York NY 10105	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-04-24	82,097	$13.70	4,901,284	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2017-04-24	10,000	$13.65	4,891,284	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2017-04-25	4,145	$13.43	4,887,139	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2017-04-25	98,143	$13.34	4,788,996	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2017-04-25	5,855	$13.43	4,783,141	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2017-04-25	138,617	$13.34	4,644,524	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

This Form 4 is filed by 21 April Ltd. ("April Ltd."), First Eagle Investment Management, LLC ("FEIM"), First Eagle Value in Biotechnology Master Fund, Ltd. ("FEVIBM") and First Eagle Holdings, Inc. ("FEHI" and, collectively with April Ltd., FEIM and FEVIBM, the "Entities"). The Entities disclaim status as a "group" for purposes of this Form 4.
The shares of Common Stock reported herein are indirectly beneficially owned by FEHI and FEIM, a Delaware limited liability company and an investment adviser registered under the Investment Advisers Act of 1940. FEIM is (i) the registered investment adviser to FEVIBM as well as to April Ltd. (collectively, the "Funds"), (ii) a subsidiary of FEHI and (iii) investment adviser to certain separately managed accounts which, together with certain separate accounts managed by Michael M. Kellen in his individual capacity holding shares reported by FEIM for which FEIM disclaims beneficial ownership are defined herein as the "Separately Managed Accounts". FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
Represents 2,599,340, 517,565 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
Represents 2,599,340, 507,565 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
Represents 2,599,340, 503,420 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
Represents 2,599,340, 405,277 and 1,784,379 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
These shares are indirectly beneficially owned by certain Separately Managed Accounts.
Represents 2,599,340, 405,277 and 1,778,524 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.
Represents 2,599,340, 405,277 and 1,639,907 shares held directly by 21 April Ltd., FEVIBM and the Separately Managed Accounts, respectively. FEHI disclaims Section 16 beneficial ownership of the shares held directly by the Funds except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that FEHI is the Section 16 beneficial owner of any such securities.